Company Description : A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction. url: www.catalystpharma.com
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphet : CORAL GABLES, Fla., June 30 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), a biopharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the...
Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.
Get the Latest Catalyst Pharmaceutical Partners stock Price, quotes, trades and FREE Catalyst Pharmaceutical Partners stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Catalyst Pharmaceutical Partners (CPRX) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.